PAPER Laurijssens B, Aujard F, Rahman A
SEARCH RESULTS
329940 RESULTS
PAPER Lublin AL, Link CD
Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.
Drug Discov Today Technol. 2013 Spring;10(1):e115-9. PubMed: 24050239PAPER Lauretani F, Ceda GP, Pelliccioni P, Ruffini L, Nardelli A, Cherubini A, Maggio M
Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons.
Curr Pharm Des. 2013 Sep 18; PubMed: 24050168PAPER Washington PM, Morffy N, Parsadanian M, Zapple D, Burns MP
Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model.
J Neurotrauma. 2013 Sep 19; PubMed: 24050316PAPER Mathis CA, Klunk WE
Imaging tau deposits in vivo: progress in viewing more of the proteopathy picture.
Neuron. 2013 Sep 18;79(6):1035-7. PubMed: 24050394PAPER Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR, Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N, Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK, Aoki I, Ito H, Higuchi M
Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.
Neuron. 2013 Sep 18;79(6):1094-108. PubMed: 24050400PAPER Clavaguera F, Grueninger F, Tolnay M
Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
Neuropharmacology. 2014 Jan;76 Pt A:9-15. PubMed: 24050961PAPER Yonezawa S, Fujiwara K, Yamamoto T, Hattori K, Yamakawa H, Muto C, Hosono M, Tanaka Y, Nakano T, Takemoto H, Arisawa M, Shuto S
Conformational restriction approach to β-secretase (BACE1) inhibitors III: Effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations.
Bioorg Med Chem. 2013 Nov 1;21(21):6506-22. PubMed: 24051074PAPER Eckert A, Nisbet R, Grimm A, Götz J
March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.
Biochim Biophys Acta. 2014 Aug;1842(8):1258-66. Epub 2013 Sep 17 PubMed: 24051203PAPER Rosenbaum R, Zimnik A, Zheng F, Turner RS, Alzheimer C, Doiron B, Rubin JE
Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation.
Neurobiol Dis. 2013 Sep 16;62C:86-99. PubMed: 24051279PAPER Antoniou M, Gunasekera GM, Wong PC
Foreign language training as cognitive therapy for age-related cognitive decline: A hypothesis for future research.
Neurosci Biobehav Rev. 2013 Sep 16; PubMed: 24051310PAPER Zhang Y, Zhang J, Hsu J, Oishi K, Faria AV, Albert M, Miller MI, Mori S
Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): Application to normal and Alzheimer's populations.
Neuroimage. 2014 Jan;84:406-19. PubMed: 24051356PAPER Melancon BJ, Tarr JC, Panarese JD, Wood MR, Lindsley CW
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.
Drug Discov Today. 2013 Sep 17; PubMed: 24051397PAPER Rosania K
Alzheimer's disease linked to brain copper buildup.
Lab Anim (NY). 2013 Oct;42(10):346. PubMed: 24051629PAPER Horner AE, Heath CJ, Hvoslef-Eide M, Kent BA, Kim CH, Nilsson SR, Alsiö J, Oomen CA, Holmes A, Saksida LM, Bussey TJ
The touchscreen operant platform for testing learning and memory in rats and mice.
Nat Protoc. 2013 Oct;8(10):1961-84. PubMed: 24051959Current Filters
No filters selected